2023年8月20日 · Reclast (sometimes called zoledronate) is a bisphosphonate medicine that alters bone formation and breakdown in the body. This can slow bone loss and may help prevent …

Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, diagnosed by bone mineral density (BMD) or prevalent vertebral …

4 mg as a single-dose intravenous infusion over no less than 15 minutes. 4 mg as retreatment after a minimum of 7 days. Reduce the dose for patients with renal impairment. Coadminister …

Reclast is given by infusion into your vein (intravenously). Your infusion should last at least 15 minutes. Before you receive Reclast, drink at least 2 glasses of fluid (such as water) within a …

Reminder: Reclast infusion should be scheduled 1 year and a day from the previous infusion date for insurance/Medicare purposes.

Reclast is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoids in a daily …

2022年7月7日 · Reclast is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic …

Consider daily supplementation with at least oral calcium 500 mg and vitamin D 400 international units unless patient has hypercalcemia. Route: Intravenous Frequency: Every 12 months …

What is Zolendronic acid (Reclast®)? Zolendronic acid is used to treat or prevent osteoporosis. Osteoporosis is a disease which causes bones to become thin. You are at risk for …

Bisphosphonates specifically act on bone cells (osteoclasts) to inhibit bone resorption and turnover activity and reduce progressive bone loss and risk for fracture. Treatment of …